Do rheumatoid factor–IgG immune complexes sustain complement activation and drive pain and fatigue?

The interaction between rheumatoid factor (RF) and immunoglobulin G (IgG) forms a critical link between autoantibody production and systemic symptoms like pain and fatigue. This process is driven by the formation of immune complexes that perpetuate inflammatory signaling.

Pathological formation and complement activation

Rheumatoid factor is an autoantibody that specifically binds to the Fc region of IgG molecules. Because RF is often polyvalent (specifically IgM-RF), it can cross-link multiple IgG molecules, forming stable, high-molecular-weight circulating immune complexes (CICs).

• Complement Cascade: These complexes are potent activators of the classical complement pathway. When the C1q protein binds to the Fc regions within the complex, it triggers a proteolytic cascade (C3 and C5 cleavage).
• Anaphylatoxin Production: This activation generates C3a and C5a (anaphylatoxins), which bind to G-protein-coupled receptors on immune cells. This results in increased vascular permeability and the massive recruitment of neutrophils and macrophages.

Mechanisms of pain and fatigue

When immune triggers persist, the resulting chronic inflammatory state directly influences the physiology of pain and fatigue through neuroimmune pathways.

• Sickness Behavior: Persistent inflammation leads to elevated levels of pro-inflammatory cytokines like IL-6 and TNF-alpha. These molecules induce "sickness behavior," a physiological state characterized by malaise and profound fatigue.
• Central Sensitization: Cytokines can signal through the vagus nerve or cross the blood-brain barrier to activate glial cells in the central nervous system. This activation leads to central sensitization, where neural networks become hyper-responsive, amplifying musculoskeletal and neuropathic pain signals.

Bottom line

The evidence strongly supports that RF-IgG immune complexes sustain complement activation and systemic inflammation. This inflammatory environment, when persistent, is a primary driver of the neurophysiological changes—such as glial activation and central sensitization—that manifest as chronic pain and fatigue.